1. |
Magne J, Mahjoub H, Dulgheru R, et al. Left ventricular contractile reserve in asymptomatic primary mitral regurgitation. Eur Heart J, 2014, 35(24): 1608-1616.
|
2. |
Pellikka PA, Arruda-Olson A, Chaudhry FA, et al. Guidelines for performance, interpretation, and application of stress echocardiography in ischemic heart disease: From the American Society of Echocardiography. J Am Soc Echocardiogr, 2020, 33(1): 1-41. e8.
|
3. |
Lancellotti P, Pellikka PA, Budts W, et al. The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging, 2016, 17(11): 1191-1229.
|
4. |
Lancellotti P, Dulgheru R, Go YY, et al. Stress echocardiography in patients with native valvular heart disease. Heart, 2018, 104(10): 807-813.
|
5. |
Gentry Iii JL, Phelan D, Desai MY, et al. The Role of stress echocardiography in valvular heart disease: A current appraisal. Cardiology, 2017, 137(3): 137-150.
|
6. |
Kossaify A, Bassil E, Kossaify M. Stress Echocardiography: Concept and criteria, structure and steps, obstacles and outcomes, focused update and review. Cardiol Res, 2020, 11(2): 89-96.
|
7. |
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: Executive summary: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 2021, 143(5): e35-e71.
|
8. |
Citro R, Bursi F, Bellino M, et al. The role of stress echocardiography in valvular heart disease. Curr Cardiol Rep, 2022, 24(10): 1477-1485.
|
9. |
Garbi M, Chambers J, Vannan MA, et al. Valve stress echocardiography: A practical guide for referral, procedure, reporting, and clinical implementation of results from the HAVEC group. JACC Cardiovasc Imaging, 2015, 8(6): 724-736.
|
10. |
Donal E, Mascle S, Brunet A, et al. Prediction of left ventricular ejection fraction 6 months after surgical correction of organic mitral regurgitation: The value of exercise echocardiography and deformation imaging. Eur Heart J Cardiovasc Imaging, 2012, 13(11): 922-930.
|
11. |
中华医学会心血管病学分会, 中国医师协会心血管内科医师分会, 中国医师协会心力衰竭专业委员会, 等. 中国心力衰竭诊断和治疗指南2024. 中华心血管病杂志, 2024, 52(3): 235-275.Chinese Society of Cardiology of Chinese Medical Association, Chinese College of Cardiovascular Physician, Chinese Heart Failure Association of Chinese Medical Doctor Association, et al. Chinese guidelines for the diagnosis and treatment of heart failure 2024. Zhonghua Xin Xue Guan Bing Za Zhi, 2024, 52(3): 235-275.
|
12. |
Lee R, Haluska B, Leung DY, et al. Functional and prognostic implications of left ventricular contractile reserve in patients with asymptomatic severe mitral regurgitation. Heart, 2005, 91(11): 1407-1412.
|
13. |
Muto C, Gasparini M, Iacopino S, et al. Efficacy of LOw-dose DObutamine Stress-Echocardiography to predict Cardiac Resynchronization Therapy response (LODO-CRT) multicenter prospective study: Design and rationale. Am Heart J, 2008, 156(4): 656-661.
|
14. |
Gasparini M, Muto C, Iacopino S, et al. Low-dose dobutamine test associated with interventricular dyssynchrony: a useful tool to identify cardiac resynchronization therapy responders: Data from the LOw dose DObutamine stress-echo test in Cardiac Resynchronization Therapy (LODO-CRT) phase 2 study. Am Heart J, 2012, 163(3): 422-429.
|
15. |
Kloosterman M, Damman K, Van Veldhuisen DJ, et al. The importance of myocardial contractile reserve in predicting response to cardiac resynchronization therapy. Eur J Heart Fail, 2017, 19(7): 862-869.
|
16. |
Geleijnse ML, Krenning BJ, van Dalen BM, et al. Factors affecting sensitivity and specificity of diagnostic testing: Dobutamine stress echocardiography. J Am Soc Echocardiogr, 2009, 22(11): 1199-1208.
|
17. |
Coisne A, Lancellotti P, Habib G, et al. EuroValve Consortium. ACC/AHA and ESC/EACTS guidelines for the management of valvular heart diseases: JACC guideline comparison. J Am Coll Cardiol, 2023, 82(8): 721-734.
|
18. |
Mogensen NSB, Ali M, Carter-Storch R, et al. Dobutamine stress echocardiography in low-gradient aortic stenosis. J Am Soc Echocardiogr, 2024, 37(11): 1023-1033.
|
19. |
Contorni F, Fineschi M, Iadanza A, et al. How to deal with low-flow low-gradient aortic stenosis and reduced left ventricle ejection fraction: From literature review to tips for clinical practice. Heart Fail Rev, 2022, 27(2): 697-709.
|
20. |
Pibarot P, Dumesnil JG. Low-flow, low-gradient aortic stenosis with normal and depressed left ventricular ejection fraction. J Am Coll Cardiol, 2012, 60(19): 1845-1853.
|
21. |
Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J, 2022, 43(7): 561-632.
|
22. |
Vitarelli A, Luzzi MF, Penco M, et al. On-line quantitative assessment of left ventricular filling during dobutamine stress echocardiography: A useful addition to conventional wall motion scoring. Int J Cardiol, 1997, 59(1): 57-69.
|
23. |
Bonow RO, Lakatos E, Maron BJ, et al. Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function. Circulation, 1991, 84(4): 1625-1635.
|
24. |
Saito C, Arai K, Ashihara K, et al. Utility of dobutamine stress echocardiography in aortic valve regurgitation and reduced left ventricular function. Echocardiography, 2022, 39(4): 599-605.
|
25. |
Ypenburg C, Sieders A, Bleeker GB, et al. Myocardial contractile reserve predicts improvement in left ventricular function after cardiac resynchronization therapy. Am Heart J, 2007, 154(6): 1160-1165.
|
26. |
Maes F, Lerakis S, Barbosa Ribeiro H, et al. Outcomes from transcatheter aortic valve replacement in patients with low-flow, low-gradient aortic stenosis and left ventricular ejection fraction less than 30%: A substudy from the TOPAS-TAVI Registry. JAMA Cardiol, 2019, 4(1): 64-70.
|
27. |
Sato K, Wang TKM, Desai MY, et al. Physical and physiological effects of dobutamine stress echocardiography in low-gradient aortic stenosis. Am J Physiol Heart Circ Physiol, 2022, 322(1): H94-H104.
|
28. |
Siontis GC, Praz F, Pilgrim T, et al. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: A meta-analysis of randomized trials. Eur Heart J, 2016, 37(47): 3503-3512.
|